Literature DB >> 6402600

Comparative study of the lipid composition of particular pathogenic and nonpathogenic species of Mycobacterium.

A K Nandedkar.   

Abstract

A comparative study was undertaken of lipid composition of Mycobacterium tuberculosis H(37)Rv and H(37)Ra, M avium, M phlei, and M 607. Neutral lipids and phosphatides constituted about 55 and 25 percent of the total lipids, respectively. Seven different phosphatides were isolated and identified in varying proportions in all of the above species of mycobacteria. These were polyglycerophosphatide, phosphatidic acid, phosphatidylethanolamine, lysophosphatidylethanolamine, phosphatidylinositol, phosphatidylinositol dimannoside, and phosphatidylinositol pentamannoside. Choline-containing phosphatides and cholesterol (steroids) were not detected in lipids of any of the five species under these defined experimental culture medium and growth conditions. Interestingly enough, neutral lipids of M tuberculosis (H(37)Rv and H(37)Ra) contained a higher percentage of diglycerides than monoglycerides, whereas in the other species (M avium, M phlei, and M 607) the monoglyceride content exceeded that of the diglycerides. It appears that the lipid composition of mycobacteria can be an additional useful parameter in distinguishing pathogenic from nonpathogenic species of mycobacteria.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6402600      PMCID: PMC2561434     

Source DB:  PubMed          Journal:  J Natl Med Assoc        ISSN: 0027-9684            Impact factor:   1.798


  18 in total

1.  Phosphorus assay in column chromatography.

Authors:  G R BARTLETT
Journal:  J Biol Chem       Date:  1959-03       Impact factor: 5.157

2.  Isolation of a new electron transport component with nicotinamide adenine dinucleotide phosphate like activity.

Authors:  W B SUTTON
Journal:  Biochem Biophys Res Commun       Date:  1963-01-18       Impact factor: 3.575

3.  Structural studies on the myo-inositol phospholipids of Mycobacterium tuberculosis (var. bovis, strain BCG).

Authors:  C E BALLOU; E VILKAS; E LEDERER
Journal:  J Biol Chem       Date:  1963-01       Impact factor: 5.157

4.  Formamidase in Mycobacteria and its use in differentiating saprophytic Myco-bacteria from other Mycobacteria.

Authors:  H NAGAYAMA; K KONNO; S OKA
Journal:  Nature       Date:  1961-06-24       Impact factor: 49.962

5.  Enzyme systems in the mycobacteria. A review.

Authors:  D S GOLDMAN
Journal:  Bibl Tuberc       Date:  1961

6.  Micromethod for the direct determination of serum triglycerides.

Authors:  E VAN HANDEL; D B ZILVERSMIT
Journal:  J Lab Clin Med       Date:  1957-07

7.  [Isolation of a phosphatidyl-inosito-di-D-mannoside from a mycobacterial phosphatide].

Authors:  E VILKAS; E LEDERER
Journal:  Bull Soc Chim Biol (Paris)       Date:  1956-04-25

8.  Rapidly growing, acid fast bacteria. I. Species' descriptions of Mycobacterium phlei Lehmann and Neumann and Mycobacterium smegmatis (Trevisan) Lehmann and Neumann.

Authors:  R E GORDON; M M SMITH
Journal:  J Bacteriol       Date:  1953-07       Impact factor: 3.490

9.  Biosynthesis of phosphatidyl ethanolamine in Mycobacterium 607.

Authors:  A K Nandedkar
Journal:  Biochem Med       Date:  1975-02

10.  Detection of sugars on paper chromatograms.

Authors:  W E TREVELYAN; D P PROCTER; J S HARRISON
Journal:  Nature       Date:  1950-09-09       Impact factor: 49.962

View more
  3 in total

1.  Reconstruction and in silico analysis of an Actinoplanes sp. SE50/110 genome-scale metabolic model for acarbose production.

Authors:  Yali Wang; Nan Xu; Chao Ye; Liming Liu; Zhongping Shi; Jing Wu
Journal:  Front Microbiol       Date:  2015-06-25       Impact factor: 5.640

2.  Investigating the metabolic capabilities of Mycobacterium tuberculosis H37Rv using the in silico strain iNJ661 and proposing alternative drug targets.

Authors:  Neema Jamshidi; Bernhard Ø Palsson
Journal:  BMC Syst Biol       Date:  2007-06-08

Review 3.  Antimicrobial Peptides Targeting Gram-Positive Bacteria.

Authors:  Nermina Malanovic; Karl Lohner
Journal:  Pharmaceuticals (Basel)       Date:  2016-09-20
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.